In this webinar, clinicians, researchers and a patient share the current state of science and safety around the cancer drug nilotinib for the treatment of Parkinson's disease. Our panel also discuss plans for future testing.
Webinar Details
Date:
Duration:
Time:
-
MJFF is not offering CME credit for this webinar. Visit webinars for our library of CME-accredited Third Thursdays webinars.